Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP5345.RAewyACRdYW_qjlyfPe0HfKbeUAMYyg2n9N6REFbUdk1A#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 15604885 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[Use of tyrosine kinase inhibitors for AML therapy is hindered by the acquisition of mutations in the kinase catalytic domain, and in the case of BCR-ABL, these mutations confer resistance to imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.